Title |
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort
|
---|---|
Published in |
Journal of Translational Medicine, June 2021
|
DOI | 10.1186/s12967-021-02937-9 |
Pubmed ID | |
Authors |
Daniele Santini, Tea Zeppola, Marco Russano, Fabrizio Citarella, Cecilia Anesi, Sebastiano Buti, Marco Tucci, Alessandro Russo, Maria Chiara Sergi, Vincenzo Adamo, Luigia S. Stucci, Melissa Bersanelli, Giulia Mazzaschi, Francesco Spagnolo, Francesca Rastelli, Francesca Chiara Giorgi, Raffaele Giusti, Marco Filetti, Paolo Marchetti, Andrea Botticelli, Alain Gelibter, Marco Siringo, Marco Ferrari, Riccardo Marconcini, Maria Giuseppa Vitale, Linda Nicolardi, Rita Chiari, Michele Ghidini, Olga Nigro, Francesco Grossi, Michele De Tursi, Pietro Di Marino, Laura Pala, Paola Queirolo, Sergio Bracarda, Serena Macrini, Stefania Gori, Alessandro Inno, Federica Zoratto, Enrica T. Tanda, Domenico Mallardo, Maria Grazia Vitale, Thomas Talbot, Paolo A. Ascierto, David J. Pinato, Corrado Ficorella, Giampiero Porzio, Alessio Cortellini |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Italy | 2 | 22% |
Colombia | 1 | 11% |
United Kingdom | 1 | 11% |
United States | 1 | 11% |
Unknown | 4 | 44% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 56% |
Scientists | 2 | 22% |
Practitioners (doctors, other healthcare professionals) | 2 | 22% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 26 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 3 | 12% |
Student > Bachelor | 2 | 8% |
Other | 2 | 8% |
Student > Doctoral Student | 1 | 4% |
Professor | 1 | 4% |
Other | 4 | 15% |
Unknown | 13 | 50% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 5 | 19% |
Economics, Econometrics and Finance | 2 | 8% |
Biochemistry, Genetics and Molecular Biology | 1 | 4% |
Computer Science | 1 | 4% |
Immunology and Microbiology | 1 | 4% |
Other | 2 | 8% |
Unknown | 14 | 54% |